PAT-3 In Vitro Growth Inhibition Activities of Natural (nCaIFN) and Recombinant (rCaIFN) Canine Interferons on Three Different Tumor-Derived Cell Lines by Priosoeryanto, Bambang Pontjo et al.
 Proc. of the 20th FAVA CONGRESS & The 15th KIVNAS PDHI, Bali Nov 1-3,  2018 | 133 
Oral Presentation (PAT-3) 
 
In Vitro Growth Inhibition Activities of Natural (nCaIFN) and Recombinant (rCaIFN) 
Canine Interferons on Three Different Tumor-Derived Cell Lines.  
 
Bambang Pontjo Priosoeryanto1*, Rizki Rostantinata1, Eva Harlina1, Lina Noviyanti2 
 
 
1Division of Veterinary Pathology, Division of Veterinary Pharmacy; Department of Veterinary Clinic, 
Reproduction & Pathology; Faculty of Veterinary Medicine;  
Bogor Agricultural University (IPB), Kampus IPB Dramaga 16680 Bogor, Indonesia 
*Corresponding author: bpontjo4@gmail.com 
 
Keywords:  Growth inhibition, interferon, in vitro, tumor cells 
 
 
INTRODUCTION 
Recently, from many kinds of diseases one 
could be counted is a tumor disease. Tumor is a 
degenerative disease that involved many biological 
pathways within the host. A tumor or neoplasm can 
be defined as a disturbance of growth 
characterized by excessive, abnormal and 
uncontrolled proliferation of transformed or 
altered cell(s) at  one or more primary points 
within the host, and frequently at  one or more 
metastatic sites (Priosoeryanto, 1994).  
The treatment of tumor is mostly by 
medical surgery which usually combined with 
chemotherapeutic agent(s), unfortunately the 
using of chemotherapeutic agent can develop a 
seriously side effect to the treated-patients. 
Biological substances like interferon (IFN) known 
as anti-virus agent is also one of promising 
candidate for treating or preventing of tumor 
disorders.  
Feline and canine squamous cell 
carcinoma is one of tumor type that often found in 
cat and dog, and mostly develop to a very 
aggressive disorder. The using of in vitro cell 
culture is a way to avoid the use of live animals on 
the study of tumors especially the study of 
antitumor agent due to can mimic the in vivo 
condition.  The aim of the present study is to 
examine the growth inhibition activity of natural 
and recombinant canine interferon in order to find 
the suitable biological substances for combating 
tumor disorder especially in the field of veterinary 
medicine and also as an information for the 
development of tumor treatment in the human 
medical side. 
 
MATERIAL AND METHODS 
Interferon Production  
The method of natural and recombinant 
canine interferons production was used of our 
previous study (Priosoeryanto et al, 2000). For the 
production of natural canine interferon (nCaIFN), 
briefly the canine MDBK cells were infected with 
the Kumarov strain of New Castle Disease virus and 
incubated for 3-4 days. The culture medium was 
then added by HCl acid until pH 2 and incubated for 
another 4 days. The medium that contain 
interferon were then collected, extracted, purified 
and stored in the refrigerator until assays was 
performed. The production of recombinant canine 
interferon (rCaIFN) was conducted based on our 
previous result (Priosoeryanto et al, 2000). The 
bioreactor method using silkworm larvae (Bombyx 
mori) that infected with a Baculovirus recombinant 
CaIFN containing plasmid was used to produce a 
sufficient amount of rCaIFN. The same assays as 
nCaIFN  to analyze the rCaIFN was also performed.  
 
 
 
 
 
Growth Inhibition Assay  
Growth inhibition assay of natural and 
recombinant canine interferon were performed 
using three tumor-derived cell lines Canine 
Squamous Cell Carcinoma (CSCC), Feline 
Squamous Cell Carcinoma (FSCC) and MCM-
IPB/B3 cell lines (Priosoeryanto et al, 1995a,b). 
Cells were cultured using microplate 24 wells  in a  
complete culture medium (DMEM, 10% FCS, and 
antibiotics). The cells were treated with 6 different 
concentrations of nCaIFN and rCaIFN started from 
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100, 101, 102, 103, 104 105 U/mL and Doxorubicin as 
a control positive. The cells were cultured in three 
replicates. Cultivated cell line was incubated in an 
incubator 37 ° C, 5% CO2. After 4 days in culture, 
the total number of cells were counted using a 
Neubauer Hemacytometer with Trypan Blue dye 
exclusion Freshney (2010). The cell number were 
then averaged and analyses for the growth 
inhibition activity (Priosoeryanto et al, 2009). 
 
RESULT AND DISCUSSION 
 Two kinds of Canine interferon were 
successfully produced by in vitro and in vivo 
methods. Both interferons were assayed for their 
growth inhibition activity in three different tumor-
derived cell lines. There is an activity of growth 
inhibition by these two types of interferons (Figure 
1 & 2). The growth inhibition activity of these two 
interferons was quietly similar in each tumor cells 
(canine and feline cells), even the activity seems 
more sensitive to the canine cells compared to the 
feline cells. These phenomenon was agreed to our 
previous study stated that type of the interferon 
more sensitive to the tumor cells from the same 
species, even there are still some significant 
activity to the different closer species 
(Priosoeryanto et al, 1995).   
 
  
 
Figure 1. The growth inhibition activity of natural 
canine interferons on three different tumor 
derived cell lines. 
 
 
Figure 2. The growth inhibition activity of 
recombinant canine interferons on three different 
tumor derived cell lines. 
 
Interferon known as an antiviral to some 
infectious diseases in human and animals (Srivasta 
et al, 2014) There are three types of interferons; 
type I interferon including alpha, beta and omega, 
binding IFN-alfa/beta receptor 1 (IFNAR1) and 
IFNAR2 subunits, type II (gamma) that binds IFN-
gamma receptor 1 (IFNGR1) and type III (lambda) 
which binds the IFN-lambda receptor 1 and IL10 
receptor subunit beta-heterodimeric receptor 
(Parker et al, 2016). 
Interferon can indeed affect cell 
proliferation in tumor cells both by prolonging or 
blocking the cell cycle (Hobeika et al, 1997), IFN 
can also regulate the apoptotic machinery by 
controlling the extrinsic and intrinsic apoptotic 
pathways (Choie et al, 2003; Thyrell et al, 2002). 
 
CONCLUSION 
Natural and recombinant canine 
interferons has a potential effect to be develop as 
an antitumor substance for treatment of tumor 
disorders in animals. We suggest a further study 
that these cytokines can be combine with some 
bioactive compound of medicinal herbs to 
increased its antitumor activity.   
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